Home/ Crypto News/ Alumis (ALMS) Stock Crashes Over 50% Following Lupus Trial Disappointment
blockonomi Sep 01, 2026

Alumis (ALMS) Stock Crashes Over 50% Following Lupus Trial Disappointment

Stocks

Alumis (ALMS) stock plummeted 56% after Phase 2b lupus trial failure. IFNGS-high subgroup showed promise. Psoriasis NDA filing still planned for Q4 2026.

The post Alumis (ALMS) Stock Crashes Over 50% Following Lupus Trial Disappointment appeared first on Blockonomi.

Source: Source: Blockonomi

Related News

Trending Category

200-day moving average 24/7 trading 4-Year Cycle AAP Stock AB 2409 AI AI Agents AI Data Centers AI IPO market AI Infrastructure AI Stocks AI automation AI backlash AI capital rotation AI spending AI trading AMD Stock AML AML compliance AMM Liquidity Pools

Latest News

Exchange Here